Company attributes
Location
B2X
Founder
Legal Name
Inhibikase Therapeutics, Inc.
Number of Employees (Ranges)
1 – 10
Email Address
info@inhibikase.com0
Phone Number
+167839234190
Full Address
3350 Riverwood Parkway Suite 1900 Atlanta, GA 303390
One Marina Park Drive Suite 1410 Boston, MA 022100
CIK Number
Place of Incorporation
DUNS Number
8283258990
Founded Date
2008
Total Funding Amount (USD)
433,000
Latest Funding Round Date
March 9, 2017
Business Model
Commerce
Stock Symbol
IKT0
Exchange
Board of Directors
Latest Funding Type
CAGE Code
57Q520
Patents Assigned (Count)
7
Country
Other attributes
Company Operating Status
Active
Contact Page URL
SIC Code
2,8360
Ticker Symbol
IKT
Inhibikase Therapeutics is a pharmaceutical company innovating small-molecule kinase inhibitor therapeutics for the treatment of neurological infections and neurodegenerative diseases.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
